✦ LIBER ✦

An open-label trial of levetiracetam for treatment of cervical dystonia

✍ Scribed by Daniel Tarsy; R. Kevin Ryan; Susie I. Ro

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 40 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20873

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open trial of levetiracetam for segme

An open trial of levetiracetam for segmental and generalized dystonia

✍ Sascha Hering; Gregor K. Wenning; Klaus Seppi; Werner Poewe; Joerg Mueller 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

## Abstract Local botulinum toxin injections represent the treatment of choice for most patients with focal dystonia. However, patients with segmental or generalized forms require additional pharmacologic treatment which is often ineffective or limited by intolerable side‐effects. An animal study a

An open trial of clozapine for dystonia

✍ Barbara Illowsky Karp; Susanne R. Goldstein; Robert Chen; Ali Samii; William Bar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

Olanzapine in the treatment of anorexia

Olanzapine in the treatment of anorexia nervosa: An open label trial

✍ Powers, Pauline S. ;Santana, Carlos A. ;Bannon, Yvonne S. 📂 Article 📅 2002 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 76 KB 👁 2 views

Open-label pilot study of levetiracetam

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease

✍ Theresa A. Zesiewicz; Kelly L. Sullivan; Robert A. Hauser; Juan Sanchez-Ramos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective open‐label pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo

Memantine in the treatment of binge eati

Memantine in the treatment of binge eating disorder: An open-label, prospective trial

✍ Brennan, Brian P. ;Roberts, Jacqueline L. ;Fogarty, Kate V. ;Reynolds, Karina A. 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 121 KB 👁 2 views

Open-label pilot study of levetiracetam

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease

✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer